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Abstract: Key Features •Synthesizes widely dispersed information on the management of gliomas into
one comprehensive resource •Chapters written by international authors who are preeminent researchers
in the field •Fully explores the therapeutic options for patient care, from chemotherapy to radiotherapy
to personalized approaches Description Researchers’ knowledge of gliomas continues to advance rapidly at
both the basic and translational levels, and Gliomas provides a thorough overview of the evolving fields
of tumor biology and clinical medicine as they relate to our understanding of brain tumors. Gliomas
reviews the current paradigms that underlie these fields, beginning with the molecular epidemiology
of glioma susceptibility and prognosis through population-based science and genome-wide association
studies. The book’s discussion of imaging modalities extends beyond advances in anatomical imaging to
include metabolic and physiological studies. This work provides thorough discussion of the clinical view of
tumors, ranging from the presentation of the patient to surgical management, and covers all therapeutic
options for patient care, including chemotherapy, targeted molecular therapies, immunotherapies, and
even personalized approaches to impact the set of lesions. Additionally, the book discusses radiotherapy
with regard to the many options available to treat patients using myriad fractionated techniques with
various sources. Finally, Gliomas reviews issues specific to the quality of life for patients, and techniques
for maximizing the effect of caregivers. Edited and authored by premier researchers from around the
world, Gliomas is a comprehensive reference for clinicians and researchers seeking the most up-to-date
information on gliomas, and a guide to the best ways to effectively manage glioma patients and their
care. Readership Researchers, clinicians and advanced students in the fields of neurology, neuro-oncology,
neurosurgery, radiation oncology, and clinical neuroscience.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-124354
Originally published at:
Berger, M; Weller, M (2016). Gliomas. Amsterdam: Elsevier.
Gliomas, 1st Edition 
• Handbook of Clinical Neurology 3rd Series 
• Foreword 
• Preface 
• Section 1: Diagnosis and treatment 
o Chapter 1: Epidemiology 
 Abstract 
 Descriptive epidemiology 
 Inherited risk factors for glioma 
 Telomere maintenance and glioma 
 Environmental and developmental risk factors 
 Patient survival following diagnosis 
 Conclusions 
 Gene abbreviations used 
 Acknowledgments 
o Chapter 2: Presenting signs and symptoms in brain tumors 
 Abstract 
 Introduction 
 Generalized symptoms and signs 
 Clinical features of increased intracranial pressure 
 Localizing symptoms and signs of intracranial neoplasms 
o Chapter 3: Neuroimaging 
 Abstract 
 Introduction 
 Conventional MRI in glioma 
 Advanced MRI techniques 
 Clinical applications of MRI 
 Role of positron emission tomography in the management of glioma 
 Conclusion 
 Acknowledgment 
o Chapter 4: Surgical approaches for the gliomas 
 Abstract 
 Introduction 
 High-grade gliomas 
 Low-grade gliomas 
 Conclusions 
o Chapter 5: Histologic classification of gliomas 
 Abstract 
 Introduction 
 Diffuse gliomas 
 Other astrocytic tumors 
 Ependymal tumors (Fig. 5.9) 
 Other gliomas (Fig. 5.10) 
 Mixed neuronal-glial tumors (Fig. 5.11) 
 Who's next: combination of histologic and molecular information 
o Chapter 6: Molecular classification of gliomas 
 Abstract 
 Introduction 
 Molecular classification of gliomas – the current state 
 Predictive molecular markers for high-grade gliomas 
 Methods in molecular diagnostics of gliomas 
 From classification to personalized treatments (Fig. 6.6) 
 Conclusions and perspectives 
 Conflicts of interest 
 Acknowledgments 
o Chapter 7: Next-generation molecular diagnostics 
 Abstract 
 Diversity and histologic classification of brain tumors 
 Limitations of morphologic grading of CNS tumors 
 Molecular biology of glioma 
 Conclusions 
o Chapter 8: Principles of radiation therapy 
 Abstract 
 Biologic principles of radiotherapy 
 Glioblastoma 
 Anaplastic glioma 
 Low-grade gliomas 
 Pilocytic astrocytoma 
 Pediatric gliomas 
 Other gliomas 
 Radiation technique 
 Brachytherapy 
 External-beam radiotherapy and proton/particle beam radiotherapy 
 Conclusions 
o Chapter 9: Principles of pharmacotherapy 
 Abstract 
 Introduction 
 The blood–brain barrier 
 The blood–tumor barrier 
 Strategies of drug delivery to the brain 
 Disrupting the blood–brain barrier 
 Intra-arterial administration 
 Intrathecal administration 
 Convection-enhanced delivery 
 Intratumoral drug delivery 
 High-dose chemotherapy 
 Drug manipulation 
 Circadian ryhthm and drug delivery 
 Other systemic therapy considerations 
 Methods of assessing drug delivery to the brain 
 Conclusion 
o Chapter 10: Principles of immunotherapy 
 Abstract 
 Introduction 
 Immunology principles 
 Immunotherapy 
 Summary 
o Chapter 11: Experimental therapies: gene therapies and oncolytic viruses 
 Abstract 
 Background 
 Viruses as therapeutic agents 
 The emerging roles of micrornas in the management of GBM 
 Stem cell-based gene therapy for malignant gliomas 
 Nanotechnology for drug/gene delivery to treat GBM 
• Section 2: Complications and symptomatic management 
o Chapter 12: Complications of glioma surgery 
 Abstract 
 Introduction 
 Complication classification schemes and complication rates 
 Mortality 
 Conclusion 
o Chapter 13: Complications from radiotherapy 
 Abstract 
 Introduction 
 Timing, mechanisms, and radiobiology of radiotherapy complications 
 Assessing complications of radiotherapy with imaging 
 Post-radiotherapy complications in the clinic: neurocognition is different from quality of 
life 
 Preventing and decreasing incidence and severity of post-RT complications 
 Perspectives 
o Chapter 14: Complications from pharmacotherapy 
 Abstract 
 Introduction and background 
 Conventional agents (Table 14.1) 
 Biologic agents (Table 14.2) 
o Chapter 15: Vascular complications in glioma patients 
 Abstract 
 Vascular complications in glioma patients 
 Venous thromboembolism in glioma patients 
 Future directions in thrombosis: applications in neuro-oncology 
 Other vascular complications in patients with glioma 
o Chapter 16: Epilepsy and brain tumors 
 Abstract 
 Incidence of epilepsy in brain tumor patients 
 Seizures as a prognostic indicator in gliomas 
 Surgical therapy 
 Antiepileptic drug therapy 
o Chapter 17: Rehabilitation of patients with glioma 
 Abstract 
 Introduction 
 Glioma and disability 
 Adverse treatment effects 
 A facilitating environment in the disease continuum 
 Rehabilitation settings 
 Exercise and fitness 
 Management of specific complications and symptoms 
 Dysphagia 
 Organizational supports 
 Conclusion 
o Chapter 18: Psycho-oncology 
 Abstract 
 Introduction 
 What is quality of life and how should it be measured? 
 What are the main threats to quality of life in glioma patients? 
 How to maintain quality of life in glioma patients 
 How to improve quality of life of informal caregivers 
 Recommendations for the future 
o Chapter 19: Palliative care at the end-of-life in glioma patients 
 Abstract 
 Introduction 
 Symptom management in the EOL phase 
 EOL decision making and advance care planning 
 Organization of EOL care 
 Role of the informal caregiver 
 Conclusion 
• Section 3: Disease-specific chapters 
o Chapter 20: Pilocytic astrocytomas 
 Abstract 
 Introduction 
 Histology 
 Biology/molecular pathways 
 General aspects of presentation 
 Imaging 
 Cerebellar pilocytic astrocytomas 
 Optic pathway pilocytic astrocytomas 
 Supratentorial hemispheric pilocytic astrocytoma 
 Brainstem pilocytic astrocytomas 
 Tectal gliomas 
 Focal brainstem pilocytic astrocytomas 
 Cervicomedullary pilocytic astrocytomas 
 Spinal pilocytic astrocytomas 
 Conclusion 
 Acknowledgments 
o Chapter 21: Astrocytic gliomas WHO grades II and III 
 Abstract 
 Clinical presentation 
 Epidemiology 
 Glioma imaging 
 Pathology 
 Molecular diagnostics 
 The rationale for maximal safe resection 
 Surgical management 
o Chapter 22: Low-grade and anaplastic oligodendroglioma 
 Abstract 
 Introduction 
 Clinical presentation and localization 
 Diagnosis 
 Prognosis 
 Treatment 
 Conclusions 
o Chapter 23: Glioblastoma 
 Abstract 
 Epidemiology and pathophysiology 
 Diagnosis and molecular classification 
 Treatment and follow-up 
 Experimental approaches and outlook 
o Chapter 24: Rare glial tumors 
 Abstract 
 Introduction 
 Subependymal giant cell astrocytoma 
 Pleomorphic xanthroastrocytoma 
 Astroblastoma 
 Chordoid glioma of the third ventricle 
 Angiocentric glioma 
 Ganglioglioma 
 Desmoplastic infantile astrocytoma and ganglioglioma 
 Dysembryoplastic neuroepithelial tumor 
 Papillary glioneuronal tumor 
 Rosette-forming glioneuronal tumor of the fourth ventricle 
 Conclusions 
o Chapter 25: Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic 
options 
 Abstract 
 Introduction 
 Epidemiology 
 Signs and symptoms 
 Imaging and growth pattern 
 Pathology 
 Molecular biology 
 Treatment and outcome 
 Conclusion 
• Index 
 
